Skip to content

FT Options LLC 13F Holdings · last filed Q3 2017

FT Options LLC reported 64 securities worth $66.36M in its SEC 13F filing for Q3 2017 (period ended 2017-09-30). Top holdings: GWPH (7.68%), INCY (6.36%), CLVS (5.23%). Among its top 25 positions this quarter: 10 new, 11 added, 3 trimmed.

RankTickerCompanyValue% PortfolioSharesAction
1GWPHGW PHARMACEUTICALS PLC$5.1M7.68%116,947Added
2INCYINCYTE CORP$4.2M6.36%119,787Added
3CLVSCLOVIS ONCOLOGY INC$3.5M5.23%155,587Trimmed
4TSROTESARO INC$3.4M5.15%72,262Added
5TEVATEVA PHARMACEUTICAL INDS LTD$2.8M4.26%379,823New
6ALNYALNYLAM PHARMACEUTICALS INC$2.1M3.20%139,800Added
7INSMINSMED INC$1.8M2.77%385,453Added
8VRTXVERTEX PHARMACEUTICALS INC$1.8M2.71%111,700Added
9BABAALIBABA GROUP HLDG LTD$1.7M2.58%19,900Hold
10ICPTINTERCEPT PHARMACEUTICALS IN$1.7M2.53%111,064New
11AKBAAKEBIA THERAPEUTICS INC$1.6M2.34%220,400Added
12PBYIPUMA BIOTECHNOLOGY INC$1.5M2.32%25,438Trimmed
13KMBKIMBERLY CLARK CORP$1.4M2.06%44,300Added
14ZGNXZOGENIX INC$1.3M2.01%129,878New
15IBBISHARES TR$1.3M2.00%37,162Trimmed
16KITEKITE PHARMA INC$1.3M2.00%113,500Added
17PLCECHILDRENS PL INC$1.3M2.00%34,000New
18SIOXAXOVANT SCIENCES LTD$1.3M2.00%527,570Added
19GILDGILEAD SCIENCES INC$1.2M1.77%171,581New
20NKENIKE INC$1.2M1.77%40,800New
21BMYBRISTOL MYERS SQUIBB CO$1.1M1.61%176,900Added
22HSICSCHEIN HENRY INC$1.1M1.59%36,148New
23DBVTDBV TECHNOLOGIES S A$1.0M1.51%127,724New
24ALXNALEXION PHARMACEUTICALS INC$939,0001.42%14,618New
25ARAVVERSARTIS INC$937,0001.41%519,940New

Source: SEC Form 13F filings · as of 2017-09-30

Every position in this 13F-HR, with its change from the prior quarter.

13F holdings, latest quarter

SourceSEC EDGAR13F-HR